X 4 Pharmaceuticals Inc (XFOR)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit

Finanzdaten der X 4 Pharmaceuticals Inc-Aktie (XFOR)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	93.78% 1.744	0.90	1.434	0.56	0.563
Cost Of Revenue	93.09% 0.326	4.716	0.302	0.227	0.268
Gross Profit	137.16% 1.418	-3.816	1.132	0.333	0.295
Operating Expenses	391.38% 27.65	5.627	36.85	34.83	-70.81
Benefits Costs and Expenses	4,600% 27.45	0.584	41.00	37.24	-90.29
Costs And Expenses	4,600% 27.45	0.584	40.26	37.24	-90.29
Operating Income/Loss	177.79% -26.23	-9.443	-35.72	-34.50	71.10
Nonoperating Income/Loss	94.59% 0.528	9.759	-3.848	-2.181	19.75
Income/Loss From Continuing Operations Before Tax	8,234% -25.70	0.316	-39.56	-36.68	90.85
Income Tax Expense/Benefit	8.82% 0.037	0.034	0.258	0.015	0.018
Income/Loss From Continuing Operations After Tax	9,228% -25.74	0.282	-39.82	-36.70	90.83
Net Income/Loss	9,228% -25.74	0.282	-39.82	-36.70	90.83
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	8.38% 7.413	6.84	0.6282	200.87	200.44
Diluted Average Shares	7.92% 7.413	6.8691	0.451	200.87	200.80
Basic Earnings Per Share	8,775% -3.47	0.04	-0.20	-0.18	0.45
Diluted Earnings Per Share	8,775% -3.47	0.04	-0.20	-0.18	0.45
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$37.30

0.64%

GMAB

$28.71

0.35%

INCY

$101.57

8.65%

BNTX

$103.95

0.04%

ONC

$311.86

0.44%

INSM

$186.23

1.78%